| RS1570658378 |
NOTCH2
|
Health Risk |
Pathogenic |
Alagille syndrome due to a NOTCH2 point mutation, Alagille syndrome due to a NOTCH2 point mutation |
| RS1570674859 |
GNB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 42 |
| RS1570679652 |
FUCA1
|
Health Risk |
Pathogenic |
Fucosidosis, Fucosidosis |
| RS1570692560 |
FUCA1
|
Health Risk |
Likely pathogenic |
Fucosidosis, Fucosidosis |
| RS1570696636 |
SZT2
|
Health Risk |
Likely pathogenic |
— |
| RS1570712875 |
COL11A1
|
Health Risk |
Likely pathogenic |
— |
| RS1570712889 |
COL11A1
|
Health Risk |
Likely pathogenic |
Fibrochondrogenesis 1, Stickler syndrome type 2 |
| RS1570714352 |
NR0B2
|
Health Risk |
Likely pathogenic |
APC-mutation negative familial colorectal cancer, Obesity |
| RS1570715470 |
NMNAT1
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 9, Leber congenital amaurosis 9 |
| RS1570725499 |
TARDBP
|
Health Risk |
Likely pathogenic |
Frontotemporal dementia, Frontotemporal dementia |
| RS1570733929 |
SZT2
|
Health Risk |
Pathogenic |
— |
| RS1570740272 |
COL11A1
|
Health Risk |
Likely pathogenic |
— |
| RS1570741194 |
SZT2
|
Health Risk |
Pathogenic |
SZT2-related disorder, SZT2-related disorder |
| RS1570752696 |
KCNA2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 32 |
| RS1570753525 |
KCNA2
|
Health Risk |
Pathogenic |
Intellectual disability, Seizure |
| RS1570753974 |
KCNA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 32 |
| RS1570759415 |
ATP13A2
|
Health Risk |
Pathogenic |
Kufor-Rakeb syndrome, Autosomal recessive spastic paraplegia type 78 |
| RS1570764426 |
LRIG2
|
Health Risk |
Likely pathogenic |
Urofacial syndrome 2, Urofacial syndrome 2 |
| RS1570781670 |
COL11A1
|
Health Risk |
Likely pathogenic |
Hearing loss, autosomal dominant 37 |
| RS1570783505 |
CTRC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary pancreatitis, Hereditary pancreatitis |
| RS1570784592 |
CTRC
|
Health Risk |
Likely pathogenic |
Hereditary pancreatitis, Hereditary pancreatitis |
| RS1570806631 |
DBT
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS1570816218 |
DBT
|
Health Risk |
Pathogenic |
Maple syrup urine disease type 2, Maple syrup urine disease type 2 |
| RS1570820579 |
DBT
|
Health Risk |
Pathogenic/Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS1570822744 |
HSD3B2
|
Health Risk |
Likely pathogenic |
— |
| RS1570823863 |
HSD3B2
|
Health Risk |
Likely pathogenic |
— |
| RS1570829502 |
MMACHC
|
Health Risk |
Pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS1570829757 |
MMACHC
|
Health Risk |
Pathogenic/Likely pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS1570829862 |
MMACHC
|
Health Risk |
Likely pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS1570833527 |
MMACHC
|
Health Risk |
Pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS1570836175 |
DBT
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS1570851702 |
ACADM
|
Health Risk |
Pathogenic/Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS1570858523 |
CEP104
|
Health Risk |
Pathogenic |
Cerebellar ataxia, Dystonic disorder |
| RS1570861829 |
ACADM
|
Health Risk |
Pathogenic/Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS1570863351 |
ACADM
|
Health Risk |
Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS1570866192 |
ACADM
|
Health Risk |
Pathogenic/Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS1570874751 |
NRAS
|
Health Risk |
Likely pathogenic |
Anemia, Noonan syndrome |
| RS1570876467 |
ACADM
|
Health Risk |
Pathogenic/Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS1570877567 |
COL11A1
|
Health Risk |
Pathogenic |
Fibrochondrogenesis 1, Fibrochondrogenesis 1 |
| RS1570891615 |
ACADM
|
Health Risk |
Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS1570893617 |
FLG
|
Health Risk |
Pathogenic |
— |
| RS1570897758 |
FLG
|
Health Risk |
Likely pathogenic |
Ichthyosis vulgaris, Ichthyosis vulgaris |
| RS1570898051 |
GLMN
|
Health Risk |
Likely pathogenic |
Glomuvenous malformation, Glomuvenous malformation |
| RS1570913142 |
FLG
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Ichthyosis vulgaris |
| RS1570929072 |
GATAD2B
|
Health Risk |
Pathogenic |
Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome, Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome |
| RS1570929867 |
GATAD2B
|
Health Risk |
Likely pathogenic |
Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome, Inborn genetic diseases |
| RS1570929904 |
GATAD2B
|
Health Risk |
Pathogenic |
Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome, Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome |
| RS1570929919 |
GATAD2B
|
Health Risk |
Pathogenic |
— |
| RS1570934766 |
ASH1L
|
Health Risk |
Pathogenic |
ASH1L-related disorder, ASH1L-related disorder |
| RS1570936325 |
GPSM2
|
Health Risk |
Likely pathogenic |
— |
| RS1570936479 |
ALX3
|
Health Risk |
Pathogenic |
Frontorhiny, Frontorhiny |
| RS1570937961 |
GATAD2B
|
Health Risk |
Pathogenic |
— |
| RS1570938014 |
GATAD2B
|
Health Risk |
Pathogenic |
Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome, Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome |
| RS1570938113 |
GATAD2B
|
Health Risk |
Likely pathogenic |
Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome, Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome |
| RS1570938310 |
ASH1L
|
Health Risk |
Pathogenic |
— |
| RS1570940216 |
FLG2
|
Health Risk |
Likely pathogenic |
— |
| RS1570941501 |
ASH1L
|
Health Risk |
Pathogenic |
— |
| RS1570944788 |
SDHB
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1570944850 |
SDHB
|
Health Risk |
Pathogenic |
Pheochromocytoma, Gastrointestinal stromal tumor |
| RS1570944890 |
SDHB
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1570945796 |
SDHB
|
Health Risk |
Pathogenic |
Gastrointestinal stromal tumor, Pheochromocytoma |
| RS1570945852 |
SDHB
|
Health Risk |
Pathogenic |
— |
| RS1570945961 |
SDHB
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary pheochromocytoma and paraganglioma |
| RS1570948527 |
SDHB
|
Health Risk |
Pathogenic |
Pheochromocytoma, Gastrointestinal stromal tumor |
| RS1570948631 |
SDHB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Pheochromocytoma/paraganglioma syndrome 4 |
| RS1570958022 |
SDHB
|
Health Risk |
Pathogenic |
Pheochromocytoma/paraganglioma syndrome 4, Pheochromocytoma |
| RS1570958038 |
SDHB
|
Health Risk |
Pathogenic |
Gastrointestinal stromal tumor, Pheochromocytoma/paraganglioma syndrome 4 |
| RS1570958090 |
SDHB
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Pheochromocytoma/paraganglioma syndrome 4 |
| RS1570963414 |
SDHB
|
Health Risk |
Likely pathogenic |
Pheochromocytoma/paraganglioma syndrome 4, Pheochromocytoma/paraganglioma syndrome 4 |
| RS1570963430 |
SDHB
|
Health Risk |
Pathogenic |
Pheochromocytoma, Gastrointestinal stromal tumor |
| RS1570963451 |
SDHB
|
Health Risk |
Pathogenic |
Pheochromocytoma, Gastrointestinal stromal tumor |
| RS1570963545 |
SDHB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Pheochromocytoma |
| RS1570964992 |
GLMN
|
Health Risk |
Pathogenic/Likely pathogenic |
Glomuvenous malformation, Glomuvenous malformation |
| RS1570980551 |
ATP1A1
|
Health Risk |
Pathogenic |
Hypomagnesemia, seizures |
| RS1570987954 |
ATP1A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hemiplegic migraine, Developmental and epileptic encephalopathy 98 |
| RS1570988755 |
ATP1A2
|
Health Risk |
Likely pathogenic |
— |
| RS1570990484 |
ATP1A2
|
Health Risk |
Pathogenic |
Familial hemiplegic migraine, Familial hemiplegic migraine |
| RS1570993763 |
GLMN
|
Health Risk |
Likely pathogenic |
Glomuvenous malformation, Glomuvenous malformation |
| RS1570994712 |
ATP1A2
|
Health Risk |
Likely pathogenic |
Familial hemiplegic migraine, Familial hemiplegic migraine |
| RS1570995017 |
ATP1A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Migraine, familial hemiplegic |
| RS1570998206 |
ATP1A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Epilepsy, Familial hemiplegic migraine |
| RS1571013274 |
PHGDH
|
Health Risk |
Pathogenic/Likely pathogenic |
PHGDH deficiency, Neu-Laxova syndrome 1 |
| RS1571024385 |
RPL5
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS1571024430 |
RPL5
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia 6, Diamond-Blackfan anemia |
| RS1571026775 |
RPL5
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia 6, Diamond-Blackfan anemia 6 |
| RS1571032029 |
RPL5
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia 6, Diamond-Blackfan anemia 6 |
| RS1571033506 |
HMGCS2
|
Health Risk |
Likely pathogenic |
3-hydroxy-3-methylglutaryl-CoA synthase deficiency, 3-hydroxy-3-methylglutaryl-CoA synthase deficiency |
| RS1571037298 |
HMGCS2
|
Health Risk |
Pathogenic |
3-hydroxy-3-methylglutaryl-CoA synthase deficiency, 3-hydroxy-3-methylglutaryl-CoA synthase deficiency |
| RS1571046516 |
ADAR
|
Health Risk |
Likely pathogenic |
— |
| RS1571046959 |
ADAR
|
Health Risk |
Pathogenic/Likely pathogenic |
Aicardi-Goutieres syndrome 6, Symmetrical dyschromatosis of extremities |
| RS1571050825 |
ADAR
|
Health Risk |
Likely pathogenic |
Symmetrical dyschromatosis of extremities, Symmetrical dyschromatosis of extremities |
| RS1571063283 |
ADAR
|
Health Risk |
Conflicting classifications of pathogenicity |
Symmetrical dyschromatosis of extremities, Aicardi-Goutieres syndrome 6 |
| RS1571065237 |
ADAR
|
Health Risk |
Pathogenic/Likely pathogenic |
Symmetrical dyschromatosis of extremities, Aicardi-Goutieres syndrome 6 |
| RS1571079651 |
COL11A1
|
Health Risk |
Likely pathogenic |
— |
| RS1571081028 |
LORICRIN
|
Health Risk |
Likely pathogenic |
— |
| RS1571089005 |
ADAR
|
Health Risk |
Pathogenic |
— |
| RS1571095986 |
ADAR
|
Health Risk |
Likely pathogenic |
— |
| RS1571110158 |
ADAR
|
Health Risk |
Likely pathogenic |
Aicardi-Goutieres syndrome 6, Aicardi-Goutieres syndrome 6 |
| RS1571110353 |
ADAR
|
Health Risk |
Pathogenic |
Symmetrical dyschromatosis of extremities, Symmetrical dyschromatosis of extremities |
| RS1571122183 |
CTSK
|
Health Risk |
Pathogenic |
8 conditions, 15 conditions |